Yüklüyor......
Predictive factors for the benefit of triple‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma
BACKGROUND: Compared with single‐drug TACE, our previous phase III study demonstrated that triple‐drug transarterial chemoembolization (TACE) prolonged overall survival (OS) in patients with unresectable hepatocellular carcinoma (HCC). The aim of this study was to find which patients can benefit fro...
Kaydedildi:
| Yayımlandı: | Cancer Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6675716/ https://ncbi.nlm.nih.gov/pubmed/31207163 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2355 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|